By Dr Kevin Ni

Journal articles

Bezerra DP; Ni J; Mohammed SI; De Miglio MR, 2024, 'Editorial: Reviews in breast cancer: 2023', Frontiers in Oncology, 14, http://dx.doi.org/10.3389/fonc.2024.1488263

Lee Y; Ni J; Beretov J; Wasinger VC; Graham P; Li Y, 2023, 'Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis', Molecular Cancer, 22, http://dx.doi.org/10.1186/s12943-023-01741-x

Lee Y; Ni J; Wasinger VC; Graham P; Li Y, 2023, 'Comparison Study of Small Extracellular Vesicle Isolation Methods for Profiling Protein Biomarkers in Breast Cancer Liquid Biopsies', International Journal of Molecular Sciences, 24, http://dx.doi.org/10.3390/ijms242015462

Bezerra DP; Ni J; Chen M, 2023, 'Editorial: Reviews in molecular and cellular oncology', Frontiers in Oncology, 13, http://dx.doi.org/10.3389/fonc.2023.1224902

Lee N; Canagasingham A; Bajaj M; Shanmugasundaram R; Hutton A; Bucci J; Graham P; Thompson J; Ni J, 2022, 'Urine exosomes as biomarkers in bladder cancer diagnosis and prognosis: From functional roles to clinical significance', Frontiers in Oncology, 12, http://dx.doi.org/10.3389/fonc.2022.1019391

Bai X; Ni J; Beretov J; Wang S; Dong X; Graham P; Li Y, 2021, 'THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple-Negative Breast Cancer', Advanced Science, 8, http://dx.doi.org/10.1002/advs.202102658

Bai X; Ni J; Beretov J; Graham P; Li Y, 2021, 'Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance', Journal of the National Cancer Center, 1, pp. 75 - 87, http://dx.doi.org/10.1016/j.jncc.2021.06.001

Bai X; Ni J; Beretov J; Wasinger VC; Wang S; Zhu Y; Graham P; Li Y, 2021, 'Activation of the eIF2α/ATF4 axis drives triple-negative breast cancer radioresistance by promoting glutathione biosynthesis', Redox Biology, 43, http://dx.doi.org/10.1016/j.redox.2021.101993

Ni K, 2021, 'Endoplasmic Reticulum Stress and Tumor Microenvironment in Bladder Cancer: The Missing Link', Frontiers in Cell and Developmental Biology, 9, pp. 683940, http://dx.doi.org/10.3389/fcell.2021.683940

Bai X; Ni J; Beretov J; Wasinger VC; Wang S; Zhu Y; Graham P; Li Y, 2021, 'Activation of the eIF2 alpha/ATF4 axis drives triple-negative breast cancer radioresistance by promoting glutathione biosynthesis', REDOX BIOLOGY, 43, http://dx.doi.org/10.1016/j.redox.2021.101993

Bai X; Ni J; Beretov J; Graham P; Li Y, 2021, 'Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel?', Cancer Letters, 497, pp. 100 - 111, http://dx.doi.org/10.1016/j.canlet.2020.10.016

Dong X; Bai X; Ni J; Zhang H; Duan W; Graham P; Li Y, 2020, 'Exosomes and breast cancer drug resistance', Cell Death and Disease, 11, http://dx.doi.org/10.1038/s41419-020-03189-z

Knox MC; Ni J; Bece A; Bucci J; Chin Y; Graham PH; Li Y; Li Y, 2020, 'A Clinician's Guide to Cancer-Derived Exosomes: Immune Interactions and Therapeutic Implications', Frontiers in Immunology, 11, pp. 1612, http://dx.doi.org/10.3389/fimmu.2020.01612

Ni J; Cheung BB; Beretov J; Duan W; Bucci J; Malouf D; Graham P; Li Y, 2020, 'CD44 variant 6 is associated with prostate cancer growth and chemo-/radiotherapy response in vivo', Experimental Cell Research, 388, http://dx.doi.org/10.1016/j.yexcr.2020.111850

Wang J; Ni J; Beretov J; Thompson J; Graham P; Li Y, 2020, 'Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer', Critical Reviews in Oncology/Hematology, 145, http://dx.doi.org/10.1016/j.critrevonc.2019.102860

Pang B; Zhu Y; Ni J; Thompson J; Malouf D; Bucci J; Graham P; Li Y, 2020, 'Extracellular vesicles: The next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis', Theranostics, 10, pp. 2309 - 2326, http://dx.doi.org/10.7150/thno.39486

Pang B; Zhu Y; Ni J; Ruan J; Thompson J; Malouf D; Bucci J; Graham P; Li Y, 2020, 'Quality assessment and comparison of plasma-derived extracellular vesicles separated by three commercial kits for prostate cancer diagnosis', International Journal of Nanomedicine, 15, pp. 10241 - 10256, http://dx.doi.org/10.2147/IJN.S283106

Ni J-S; Li Y; Yue W; Liu B; Li K, 2020, 'Nanoparticle-based Cell Trackers for Biomedical Applications.', Theranostics, 10, pp. 1923 - 1947, http://dx.doi.org/10.7150/thno.39915

Tsao T; Beretov J; Ni J; Bai X; Bucci J; Graham P; Li Y, 2019, 'Cancer stem cells in prostate cancer radioresistance', Cancer Letters, 465, pp. 94 - 104, http://dx.doi.org/10.1016/j.canlet.2019.08.020

Ni J; Bucci J; Malouf D; Knox M; Graham P; Li Y, 2019, 'Exosomes in Cancer Radioresistance', Frontiers in Oncology, 9, http://dx.doi.org/10.3389/fonc.2019.00869

Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y, 2019, 'Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression', BMC Cancer, 19, http://dx.doi.org/10.1186/s12885-019-5824-9

Feng X; Bai X; Ni J; Wasinger VC; Beretov J; Zhu Y; Graham P; Li Y, 2019, 'CHTOP in chemoresistant epithelial ovarian cancer: A novel and potential therapeutic target', Frontiers in Oncology, 9, pp. 557, http://dx.doi.org/10.3389/fonc.2019.00557

Ni J; Bongers A; Chamoli U; Bucci J; Graham P; Li Y, 2019, 'In Vivo 3D MRI Measurement of Tumour Volume in an Orthotopic Mouse Model of Prostate Cancer', Cancer Control, 26, http://dx.doi.org/10.1177/1073274819846590

Chang L; Ni J; Zhu Y; Pang B; Graham P; Zhang H; Li Y, 2019, 'Liquid biopsy in ovarian cancer: Recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression', Theranostics, 9, pp. 4130 - 4140, http://dx.doi.org/10.7150/thno.34692

Ni J; Cozzi P; Beretov J; Duan W; Bucci J; Graham P; Li Y, 2018, 'Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo', BMC Cancer, 18, pp. 1092, http://dx.doi.org/10.1186/s12885-018-5010-5

Bai X; Ni J; Beretov J; Graham P; Li Y, 2018, 'Cancer stem cell in breast cancer therapeutic resistance', Cancer Treatment Reviews, 69, pp. 152 - 163, http://dx.doi.org/10.1016/j.ctrv.2018.07.004

Wu D; Ni J; Beretov J; Cozzi P; Willcox M; Wasinger V; Walsh B; Graham P; Li Y, 2017, 'Urinary biomarkers in prostate cancer detection and monitoring progression', Critical Reviews in Oncology/Hematology, 118, pp. 15 - 26, http://dx.doi.org/10.1016/j.critrevonc.2017.08.002

Chang L; Ni J; Beretov J; Wasinger VC; Hao J; Bucci J; Malouf D; Gillatt D; Graham PH; Li Y, 2017, 'Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach', Scientific Reports, 7, pp. 41834, http://dx.doi.org/10.1038/srep41834

Ni J; Bucci J; Chang L; Malouf D; Graham P; Li Y, 2017, 'Targeting microRNAs in prostate cancer radiotherapy', Theranostics, 7, pp. 3243 - 3259, http://dx.doi.org/10.7150/thno.19934

Deng J; Wang L; Ni J; Beretov J; Wasinger V; Wu D; Duan W; Graham P; Li Y, 2016, 'Proteomics discovery of chemoresistant biomarkers for ovarian cancer therapy', Expert Review of Proteomics, http://dx.doi.org/10.1080/14789450.2016.1233065

Ni J; Cozzi P; Hung T; Hao J; Graham PH; Li Y, 2016, 'Monitoring Prostate Tumor Growth in an Orthotopic Mouse Model Using Three-Dimensional Ultrasound Imaging Technique', Translational Oncology, 9, pp. 41 - 45, http://dx.doi.org/10.1016/j.tranon.2015.11.011

Chang L; Graham P; Hao J; Ni J; Deng J; Bucci J; Malouf D; Gillatt D; Li Y, 2016, 'Cancer stem cells and signaling pathways in radioresistance', Oncotarget, 7, pp. 11002 - 11017, http://dx.doi.org/10.18632/oncotarget.6760

Hao J; Graham P; Chang L; Ni J; Wasinger V; Beretov J; Deng J; Duan W; Bucci J; Malouf D; Gillatt D; Li Y, 2016, 'Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy', Oncotarget, 7, pp. 74269 - 74285, http://dx.doi.org/10.18632/oncotarget.12368

Deng J; Wang L; Chen H; Hao J; Ni J; Chang L; Duan W; Graham P; Li Y, 2016, 'Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer', Oncotarget, 7, pp. 55771 - 55788, http://dx.doi.org/10.18632/oncotarget.9908

Chang L; Graham PH; Ni J; Hao J; Bucci J; Cozzi PJ; Li Y, 2015, 'Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance', Critical Reviews in Oncology/Hematology, 96, pp. 507 - 517, http://dx.doi.org/10.1016/j.critrevonc.2015.07.005

Lei C; Wasinger V; Graham P; Hao J; Ni J; Beretov J; Bucci J; Cozzi P; Kearsley J; Li Y, 2014, 'THE USE OF LABEL-FREE LC-MS/MS APPROACH TO IDENTIFY SIGNALING PATHWAYS ASSOCIATED WITH PROSTATE CANCER RADIORESISTANCE', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 10, pp. 130 - 130, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000345350900164&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ni J; Cozzi P; Hao J; Duan W; Graham P; Kearsley J; Li Y, 2014, 'Cancer stem cells in prostate cancer chemoresistance', Current Cancer Drug Targets, 14, pp. 225 - 240, http://dx.doi.org/10.2174/1568009614666140328152459

Chang L; Graham PH; Hao J; Ni J; Bucci J; Cozzi PJ; Kearsley JH; Li Y, 2014, 'PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways', Cell Death and Disease, 5, http://dx.doi.org/10.1038/cddis.2014.415

Ni J; Cozzi PJ; Hao JL; Beretov J; Chang L; Duan W; Shigdar S; Delprado WJ; Graham PH; Bucci J; Kearsley JH; Li Y, 2014, 'CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance', The Prostate, 74, pp. 602 - 617, http://dx.doi.org/10.1002/pros.22775

Deng J; Wang L; Chen H; Li L; Ma Y; Ni J; Li Y, 2013, 'The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression', Cancer and Metastasis Reviews, 32, pp. 535 - 551, http://dx.doi.org/10.1007/s10555-013-9423-y

Chang L; Graham P; Hao J; Ni J; Bucci J; Cozzi P; Kearseley J; Li Y, 2013, 'PI3K/Akt/mTOR dual inhibitors have an advantage over single inhibitors in overcoming prostate cancer radioresistance.', MOLECULAR CANCER THERAPEUTICS, 12, http://dx.doi.org/10.1158/1535-7163.TARG-13-A283

Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y, 2013, 'Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway', International Journal of Biochemistry and Cell Biology, 45, pp. 2736 - 2748, http://dx.doi.org/10.1016/j.biocel.2013.09.008

Chang L; Graham PH; Hao J; Ni J; Bucci J; Cozzi PJ; Kearsley JH; Li Y, 2013, 'Acquisition of epithelialmesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance', Cell Death and Disease, 4, http://dx.doi.org/10.1038/cddis.2013.407

Xiao W; Graham PH; Hao J; Chang L; Ni J; Power CA; Dong Q; Kearsley JH; Li Y, 2013, 'Combination Therapy with the Histone Deacetylase Inhibitor LBH589 and Radiation Is an Effective Regimen for Prostate Cancer Cells', PLoS ONE, 8, http://dx.doi.org/10.1371/journal.pone.0074253

Hao J; Ni J; Cozzi PJ; Graham PH; Bucci J; Kearsley J; Li Y, 2013, 'The CD44 Isoforms in Prostate Cancer Metastasis and progression', World Journal of Cancer Research, 1, pp. 3 - 14, http://dx.doi.org/10.1166/wjcr.2013.1009

Conference Papers

Bai X; Ni J; Li Y; Beretov J, 2020, 'Abstract 6163: Integrated stress response contributes to triple negative breast cancer radioresistance by regulating glutathione biosynthesis', in Cancer Research, American Association for Cancer Research (AACR), pp. 6163 - 6163, http://dx.doi.org/10.1158/1538-7445.am2020-6163

Bai X; Feng X; Ni J; Beretov J; Deng J; Zhu Y; Graham P; Li Y, 2019, 'Abstract 4754: CHTOP is a novel therapeutic target for chemoresistant epithelial ovarian cancer therapy', in Cancer Research, American Association for Cancer Research (AACR), pp. 4754 - 4754, http://dx.doi.org/10.1158/1538-7445.am2019-4754

Ni J; Cozzi P; Beretov J; Bucci J; Graham P; Li Y, 2018, 'Study of CD44 variant 6 (CD44v6) in prostate cancer chemo-/radio resistance in vivo', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, IL, Chicago, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), IL, Chicago, 14 April 2018 - 18 April 2018, http://dx.doi.org/10.1158/1538-7445.AM2018-1999

Ni J; Cozzi P; Beretov J; Deng J; Bucci J; Graham P; Li Y, 2017, 'Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer progression and chemo/radio-resistance in vitro and in vivo', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, DC, Washington, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), DC, Washington, 01 April 2017 - 05 April 2017, http://dx.doi.org/10.1158/1538-7445.AM2017-2833

Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Delprado W; Graham P; Bucci J; Kearsley J; Li Y, 2014, 'CD44 isoform variant 6 is associated with prostate cancer progression, metastasis and chemo-/radio-resistance via PI3K/Akt/mTOR and Wnt/beta-catenin signaling pathways in vitro', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, presented at 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2014 - 09 April 2014, http://dx.doi.org/10.1158/1538-7445.AM2014-4005

Back to profile page